Clinical Application Effects of Different Preoperative Blood Management Schemes in Older Patients with Delayed Intertrochanteric Fracture Surgery

References

• Zhang C, Feng J, Wang S, et al. Incidence of and trends in hip fracture among adults in urban China: a nationwide retrospective cohort study. PLoS Med. 2020;17:e1003180. doi:10.1371/journal.pmed.1003180
   PubMed Web of Science ®Google Scholar
• Ren Y, Hu J, Lu B, Zhou W, Tan B. Prevalence and risk factors of hip fracture in a middle-aged and older Chinese population. Bone. 2019;122:143–149. doi:10.1016/j.bone.2019.02.020
   PubMed Web of Science ®Google Scholar
• Cui Z, Feng H, Meng X, et al. Age-specific 1-year mortality rates after hip fracture based on the populations in mainland China between the years 2000 and 2018: a systematic analysis. Arch Osteoporos. 2019;14:55. doi:10.1007/s11657-019-0604-3
   PubMed Web of Science ®Google Scholar
• Yombi JC, Putineanu DC, Cornu O, et al. Low haemoglobin at admission is associated with mortality after hip fractures in elderly patients. Bone Joint J. 2019;101-b:1122–1128. doi:10.1302/0301-620x.101b9.bjj-2019-0526.r1
   PubMed Web of Science ®Google Scholar
• Espinosa KA, Gélvez AG, Torres LP, García MF, Peña OR. Pre-operative factors associated with increased mortality in elderly patients with a hip fracture: a cohort study in a developing country. Injury. 2018;49:1162–1168. doi:10.1016/j.injury.2018.04.007
   PubMed Web of Science ®Google Scholar
• Dao P, Massin P. Blood management in enhanced recovery after hip and knee replacement. Orthop Traumatol Surg Res. 2020;106:S1–S5. doi:10.1016/j.otsr.2019.05.022
   PubMed Web of Science ®Google Scholar
• Zhang S, Huang Q, Xu B, et al. Effectiveness and safety of an optimized blood management program in total hip and knee arthroplasty: a large, single-center, retrospective study. Medicine. 2018;97:e9429. doi:10.1097/md.0000000000009429
   PubMed Web of Science ®Google Scholar
• Shakur H, Roberts I, Bautista R, et al. Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial. Lancet. 2010;376:23–32. doi:10.1016/s0140-6736(10)60835-5
   PubMed Web of Science ®Google Scholar
• Farrow LS, Smith TO, Ashcroft GP, Myint PK. A systematic review of tranexamic acid in hip fracture surgery. Br J Clin Pharmacol. 2016;82:1458–1470. doi:10.1111/bcp.13079
   PubMed Web of Science ®Google Scholar
• Tian S, Shen Z, Liu Y, Zhang Y, Peng A. The effect of tranexamic acid on hidden bleeding in older intertrochanteric fracture patients treated with PFNA. Injury. 2018;49:680–684. doi:10.1016/j.injury.2018.01.026
   PubMed Web of Science ®Google Scholar
• Lei J, Zhang B, Cong Y, et al. Tranexamic acid reduces hidden blood loss in the treatment of intertrochanteric fractures with PFNA: a single-center randomized controlled trial. J Orthop Surg Res. 2017;12:124. doi:10.1186/s13018-017-0625-9
   PubMed Web of Science ®Google Scholar
• Ma H, Wang H, Long X, et al. Early intravenous tranexamic acid intervention reduces post-traumatic hidden blood loss in elderly patients with intertrochanteric fracture: a randomized controlled trial. J Orthop Surg Res. 2021;16:106. doi:10.1186/s13018-020-02166-8
   PubMed Web of Science ®Google Scholar
• Mueller MM, Van Remoortel H, Meybohm P, et al. Patient blood management: recommendations from the 2018 Frankfurt consensus conference. JAMA. 2019;321:983–997. doi:10.1001/jama.2019.0554
   PubMed Web of Science ®Google Scholar
• Bernabeu-Wittel M, Romero M, Ollero‐Baturone M, et al. Ferric carboxymaltose with or without erythropoietin in anemic patients with hip fracture: a randomized clinical trial. Transfusion. 2016;56:2199–2211. doi:10.1111/trf.13624
   PubMed Web of Science ®Google Scholar
• Koo CH, Shin HJ, Cho H, Ryu JH. The effect of perioperative intravenous iron on hemoglobin in surgical patients: a meta-analysis. J Surg Res. 2020;246:42–51. doi:10.1016/j.jss.2019.08.023
   PubMed Web of Science ®Google Scholar
• Gregersen M, Borris LC, Damsgaard EM. Postoperative blood transfusion strategy in frail, anemic elderly patients with hip fracture: the TRIFE randomized controlled trial. Acta Orthop. 2015;86:363–372. doi:10.3109/17453674.2015.1006980
   PubMed Web of Science ®Google Scholar
• Smith GH, Tsang J, Molyneux SG, White TO. The hidden blood loss after hip fracture. Injury. 2011;42:133–135. doi:10.1016/j.injury.2010.02.015
   PubMed Web of Science ®Google Scholar
• Wu JZ, Liu PC, Ge W, Cai M. A prospective study about the preoperative total blood loss in older people with hip fracture. Clin Interv Aging. 2016;11:1539–1543. doi:10.2147/cia.s120526
   PubMed Web of Science ®Google Scholar
• Li B, Li J, Wang S, Liu L. Clinical analysis of peri-operative hidden blood loss of elderly patients with intertrochanteric fractures treated by unreamed proximal femoral nail anti-rotation. Sci Rep. 2018;8:3225. doi:10.1038/s41598-018-21703-4
   PubMed Web of Science ®Google Scholar
• Roberts I, Roberts I, Shakur H, et al. The importance of early treatment with tranexamic acid in bleeding trauma patients: an exploratory analysis of the CRASH-2 randomised controlled trial. Lancet. 2011;377:1096–1101. doi:10.1016/S0140-6736(11)60278-X
   PubMed Web of Science ®Google Scholar
• Banerjee A, Silliman CC, Moore EE, et al. Systemic hyperfibrinolysis after trauma: a pilot study of targeted proteomic analysis of superposed mechanisms in patient plasma. J Trauma Acute Care Surg. 2018;84:929–938. doi:10.1097/ta.0000000000001878
   PubMed Web of Science ®Google Scholar
• Yoon BH, Lee BS, Won H, et al. Preoperative iron supplementation and restrictive transfusion strategy in hip fracture surgery. Clin Orthop Surg. 2019;11:265–269. doi:10.4055/cios.2019.11.3.265
   PubMed Web of Science ®Google Scholar
• Muñoz M, Gómez-Ramírez S, Cuenca J, et al. Very-short-term perioperative intravenous iron administration and postoperative outcome in major orthopedic surgery: a pooled analysis of observational data from 2547 patients. Transfusion. 2014;54:289–299. doi:10.1111/trf.12195
   PubMed Web of Science ®Google Scholar
• García-Erce JA, Cuenca J, Haman-Alcober S, et al. Efficacy of preoperative recombinant human erythropoietin administration for reducing transfusion requirements in patients undergoing surgery for hip fracture repair. An observational cohort study. Vox Sanguinis. 2009;97:260–267. doi:10.1111/j.1423-0410.2009.01200.x
   PubMed Web of Science ®Google Scholar
• Jeong JH, Chang MJ, Kang S-B, et al. Postoperative intravenous iron supplementation does not improve hemoglobin level and transfusion rate following staged bilateral total knee arthroplasty. J Arthroplasty. 2020;35:2444–2450. doi:10.1016/j.arth.2020.04.086
   PubMed Web of Science ®Google Scholar
• Gupta PB, DeMario VM, Amin RM, et al. Patient blood management program improves blood use and clinical outcomes in orthopedic surgery. Anesthesiology. 2018;129:1082–1091. doi:10.1097/aln.0000000000002397
   PubMed Web of Science ®Google Scholar
• Kang Y, Liu J, Chen H, et al. Enhanced recovery after surgery (ERAS) in elective intertrochanteric fracture patients result in reduced length of hospital stay (LOS) without compromising functional outcome. J Orthop Surg Res. 2019;14:209. doi:10.1186/s13018-019-1238-2
   PubMed Web of Science ®Google Scholar
• Rosso F, Dettoni F, Bonasia DE, et al. Prognostic factors for mortality after hip fracture: operation within 48 hours is mandatory. Injury. 2016;47:S91–S97. doi:10.1016/j.injury.2016.07.055
   PubMed Web of Science ®Google Scholar
• Moran CG, Wenn RT, Sikand M, Taylor AM. Early mortality after hip fracture: is delay before surgery important? J Bone Joint Surg Am. 2005;87:483–489. doi:10.2106/jbjs.d.01796
   PubMed Web of Science ®Google Scholar
• Raman T, Varlotta C, Vasquez-Montes D, Buckland AJ, Errico TJ. The use of tranexamic acid in adult spinal deformity: is there an optimal dosing strategy? Spine J. 2019;19:1690–1697. doi:10.1016/j.spinee.2019.06.012
   PubMed Web of Science ®Google Scholar
• Xie J, Hu Q, Ma J, Huang Q, Pei F. Multiple boluses of intravenous tranexamic acid to reduce hidden blood loss and the inflammatory response following enhanced-recovery primary total hip arthroplasty: a randomised clinical trial. Bone Joint J. 2017;99-b:1442–1449. doi:10.1302/0301-620x.99b11.bjj-2017-0488.r1
   PubMed Web of Science ®Google Scholar
• Lin ZX, Woolf SK. Safety, efficacy, and cost-effectiveness of tranexamic acid in orthopedic surgery. Orthopedics. 2016;39:119–130. doi:10.3928/01477447-20160301-05
   PubMed Web of Science ®Google Scholar
• Unger EF, Thompson AM, Blank MJ, Temple R. Erythropoiesis-stimulating agents–time for a reevaluation. N Engl J Med. 2010;362:189–192. doi:10.1056/NEJMp0912328
   PubMed Web of Science ®Google Scholar
• Muñoz M, García-Erce JA, Villar I, Thomas D. Blood conservation strategies in major orthopaedic surgery: efficacy, safety and European regulations. Vox Sang. 2009;96:1–13. doi:10.1111/j.1423-0410.2008.01108.x
   PubMed Web of Science ®Google Scholar
• Avni T, Bieber A, Grossman A, et al. The safety of intravenous iron preparations: systematic review and meta-analysis. Mayo Clin Proc. 2015;90:12–23. doi:10.1016/j.mayocp.2014.10.007
   PubMed Web of Science ®Google Scholar
• Greenstein AS, Gorczyca JT. Orthopedic surgery and the geriatric patient. Clin Geriatr Med. 2019;35:65–92. doi:10.1016/j.cger.2018.08.007
   PubMed Web of Science ®Google Scholar
• Gross JB. Estimating allowable blood loss: corrected for dilution. Anesthesiology. 1983;58:277–280. doi:10.1097/00000542-198303000-00016
   PubMed Web of Science ®Google Scholar
• Nadler SB, Hidalgo JH, Bloch T. Prediction of blood volume in normal human adults. Surgery. 1962;51:224–232.
   PubMed Web of Science ®Google Scholar